Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Rhythm Pharmaceuticals Launches Hypothalamic Obesity Treatment in Japan

Rhythm Pharmaceuticals Launches Hypothalamic Obesity Treatment in Japan

MT newswireMT newswire2026/10/14 08:32
04:32 AM EDT, 10/14/2026 (MT Newswires) -- Rhythm Pharmaceuticals (RYTM) launched Imcivree in Japan for the treatment of acquired hypothalamic obesity, the company said late Tuesday. Hypothalamic obesity is a rare, serious condition that can result in weight gain and uncontrollable hunger.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!